R. Shiloh

发表

A model-driven methodology for exploring complex disease comorbidities applied to autism spectrum disorder and inflammatory bowel disease

Monika Heiner, Mor Peleg, Isaac S. Kohane, 2016, J. Biomed. Informatics.

6,7,4'-Trihydroxyisoflavan: a potent and selective inhibitor of 5-lipoxygenase in human and porcine peripheral blood leukocytes.

H. Jha, P. Kuhl, F. Zilliken, 1984, Prostaglandins.

Ser289 phosphorylation activates both DAPK1 and DAPK2 but in response to different intracellular signaling pathways

A. Kimchi, S. Bialik, R. Shiloh, 2019, Cell cycle.

DAPK2 is a novel regulator of mTORC1 activity and autophagy

A. Kimchi, S. Bialik, Y. Ber, 2014, Cell Death and Differentiation.

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.

E. Domany, A. Borkhardt, D. Bercovich, 2010, Blood.

mutated JAK2: a report from the International BFM Study Group disease in which aberrant expression of CRLF2 is associated with Down syndrome acute lymphoblastic leukemia, a highly heterogeneous

E. Domany, A. Borkhardt, D. Bercovich, 2013 .

The DAPK family: a structure–function analysis

A. Kimchi, S. Bialik, R. Shiloh, 2014, Apoptosis.

Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagy

M. Eisenstein, A. Kimchi, S. Bialik, 2018, Nature Communications.

Discovering protein-protein interactions within the programmed cell death network using a protein-fragment complementation screen.

A. Kimchi, S. Bialik, Y. Ber, 2014, Cell reports.

Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagy

M. Eisenstein, A. Kimchi, S. Bialik, 2018, Nature Communications.

Mechanisms of Leukemia Evolution: Lessons from a Congenital Syndrome.

S. Izraeli, Y. Birger, R. Shiloh, 2019, Cancer cell.

DOWN'S Syndrome Acute Lymphoblastic LEUKEMIA: A HIGHLY Heterogeneous DISEASE DRIVEN by an Aberrant CRLF2/JAK2 Cooperation – A REPORT FROM the Ibfm-STUDY GROUP.

E. Domany, D. Bercovich, G. Kronnie, 2009 .

AMPK activates DAPK2 to promote autophagy

A. Kimchi, R. Shiloh, 2018, Oncotarget.

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.

E. Domany, R. Arceci, A. Borkhardt, 2010, Blood.